Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
🌎 Global
Global
United States
Australia
United Kingdom
Canada
India
China
Argentina
Austria
Bahrain
Bangladesh
Belgium
Bermuda
Botswana
Brazil
Bulgaria
Chile
Colombia
Croatia
Cyprus
Czech Republic
Denmark
Egypt
Estonia
Finland
France
Germany
Ghana
Greece
Hong Kong
Hungary
Iceland
Indonesia
Ireland
Israel
Italy
Ivory Coast
Jamaica
Japan
Jordan
Kenya
Kuwait
Latvia
Lithuania
Luxembourg
Malawi
Malaysia
Malta
Mauritius
Mexico
Morocco
Namibia
Netherlands
New Zealand
Nigeria
Norway
Oman
Pakistan
Palestinian Authority
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russia
Saudi Arabia
Serbia
Singapore
Slovakia
Slovenia
South Africa
South Korea
Spain
Sri Lanka
Sweden
Switzerland
Taiwan
Tanzania
Thailand
Trinidad & Tobago
Tunisia
Turkey
Uganda
Ukraine
United Arab Emirates
Venezuela
Vietnam
Zambia
Zimbabwe
Create a narrative
Global Community
Our community narratives are driven by numbers and valuation.
Create a narrative
Community Investing Ideas
Global Weekly Picks
GXAI
Gaxos.ai
Sponsored
content by Gaxos.ai
JO
Jolt_Communications
Community Contributor
Gaxos.ai: Early-Stage AI Innovator in Gaming & Health
Key Takeaways Dual AI focus – Gaxos.ai builds AI-powered tools for game developers (via Unity integrations) and AI-driven health services under its RNK Health brand. First signs of commercial traction – After years of development, the company reported ~$194k in H1 2025 revenue, mainly from wellness pilot programs.
View narrative
US$2.21
FV
24.9% overvalued
intrinsic discount
119.00%
Revenue growth p.a.
Set Fair Value
1
users have liked this narrative
1
users have commented on this narrative
21
users have followed this narrative
Updated
narrative
Microsoft
PI
PicaCoder
Community Contributor
After the AI Party: A Sobering Look at Microsoft's Future
The world has been captivated by the artificial intelligence boom, and no company has ridden the wave of investor enthusiasm quite like Microsoft. Buoyed by its strategic partnership with OpenAI and the integration of AI across its product ecosystem, the company's valuation has soared to unprecedented heights.
View narrative
US$500.00
FV
0.8% overvalued
intrinsic discount
6.75%
Revenue growth p.a.
Set Fair Value
19
users have liked this narrative
9
users have commented on this narrative
24
users have followed this narrative
10 days ago
author updated this narrative
Amazon.com
ZW
Zwfis
Community Contributor
Amazon's Future Rises as Stock Price Falls: A Long-Term Investment Vision
Amazon is a stock I am very interested in right now especially with the recent price drops that it has been experiencing since its 2Q25 results. A summary of Amazon as stated by Fiscal.ai: "Amazon.com, Inc.
View narrative
US$234.75
FV
5.5% undervalued
intrinsic discount
13.60%
Revenue growth p.a.
Set Fair Value
18
users have liked this narrative
7
users have commented on this narrative
22
users have followed this narrative
New
narrative
Verve Group
TI
TibiT
Community Contributor
Verve Group: A Tale of Three Futures
Verve Group stands at a critical juncture. After a history of explosive growth, the company has been hit by significant operational headwinds, primarily the difficult and costly migration to a unified technology platform and unfavorable currency exchange rates.
View narrative
€4.02
FV
45.5% undervalued
intrinsic discount
8.50%
Revenue growth p.a.
Set Fair Value
3
users have liked this narrative
0
users have commented on this narrative
15
users have followed this narrative
Updated
narrative
All companies
Popular
Undervalued
Overvalued
Load previous narratives
LiveOne
AN
AnalystHighTarget
Consensus Narrative from 2 Analysts
Mobile Internet And Subscription Models Will Redefine Entertainment
Key Takeaways Rapid expansion of high-value partnerships and advanced monetization strategies position LiveOne for outsized revenue, subscriber growth, and margin improvement versus market expectations. Emphasis on digital innovation, automation, and new asset classes strengthens operational leverage, enhances recurring earnings, and creates unique avenues for shareholder value.
View narrative
US$2.70
FV
78.1% undervalued
intrinsic discount
17.58%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
1 day ago
author updated this narrative
Skillz
AN
AnalystHighTarget
Consensus Narrative from 2 Analysts
Mobile Gaming And Digital Payments Will Expand Global Markets
Key Takeaways Rapid innovation, reduced acquisition costs, and advanced ad tech integration position Skillz for much faster, sustainable growth and operating leverage than peers anticipate. Strategic product rollouts and reputation as a trusted platform should boost user engagement, expand market share, and drive superior recurring revenue and earnings quality.
View narrative
US$14.00
FV
39.7% undervalued
intrinsic discount
19.22%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
1
users have followed this narrative
1 day ago
author updated this narrative
Stem
AN
AnalystHighTarget
Consensus Narrative from 6 Analysts
Global Decarbonization And Athena Trends Will Supercharge Renewable Demand
Key Takeaways Organizational restructuring, AI-enabled products, and increased financial flexibility are driving stronger transparency, operational efficiency, and global market expansion, strengthening Stem's competitive position. Rapid SaaS growth, high retention rates, and rising demand for energy storage are accelerating recurring revenue, gross margin, and long-term earnings beyond peer expectations.
View narrative
US$17.00
FV
10.1% undervalued
intrinsic discount
33.18%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
2
users have followed this narrative
1 day ago
author updated this narrative
Lineage Cell Therapeutics
AN
AnalystHighTarget
Consensus Narrative from 6 Analysts
Rapid Advances Will Redefine Regenerative Medicine For Aging Populations
Key Takeaways OpRegen's clinical progress and the Roche partnership could make Lineage a disruptive leader in cell therapy with much higher adoption and earnings than expected. Scalable technology and a broad pipeline position the company for accelerated growth, premium acquisition potential, and expanded industry partnerships.
View narrative
US$8.85
FV
86.8% undervalued
intrinsic discount
105.19%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
1 day ago
author updated this narrative
LivePerson
AN
AnalystHighTarget
Consensus Narrative from 3 Analysts
Google Cloud And Databricks Will Fuel AI Customer Engagement
Key Takeaways Rapid generative AI adoption and digital transformation position LivePerson as a potential category leader, enabling outsized market share gains and structurally higher profitability. Strategic balance sheet improvements and specialized, secure AI offerings make LivePerson a trusted, de-risked partner for large enterprises, spurring long-term contract wins and recurring revenue growth.
View narrative
US$1.50
FV
25.3% undervalued
intrinsic discount
-11.38%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
New
narrative
Quest Resource Holding
AN
AnalystHighTarget
Consensus Narrative from 3 Analysts
Growing Regulatory Focus And Circular Economy Practices Will Fuel Transformation
Key Takeaways Significant operational efficiencies and digital transformation are driving stronger profitability, margin expansion, and long-term cash flow generation. Strategic positioning in sustainable waste management and major client wins are accelerating high-quality, recurring revenue growth and improving long-term industry prospects.
View narrative
US$4.00
FV
60.3% undervalued
intrinsic discount
-1.89%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
New
narrative
LightPath Technologies
AN
AnalystHighTarget
Consensus Narrative from 5 Analysts
IoT Expansion And Automation Will Fuel Optical Market Demand
Key Takeaways Acquisition-driven recurring defense revenues, proprietary materials, and government-backed capacity investment could result in transformational scale, accelerating margins and earnings beyond consensus. Supply chain disruptions and export restrictions position LightPath for market share gains and premium pricing as a safe-harbor supplier, driving robust and visible growth.
View narrative
US$5.50
FV
31.1% undervalued
intrinsic discount
33.07%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
1 day ago
author updated this narrative
NN
AN
AnalystHighTarget
Consensus Narrative from 4 Analysts
Global Automation And Electrification Will Expand Market Opportunities
Key Takeaways Growth in premium markets, operational efficiencies, and strategic acquisitions position NN for strong revenue expansion and structurally higher profit margins. Investments in specialized products and regulatory certifications enable NN to secure preferred contracts, expand recurring revenue, and gain lasting market share advantages.
View narrative
US$7.00
FV
66.6% undervalued
intrinsic discount
4.04%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
1 day ago
author updated this narrative
Sight Sciences
AN
AnalystHighTarget
Consensus Narrative from 6 Analysts
Aging Demographics And Emerging Markets Will Expand Eye Care Access
Key Takeaways Rapid product innovation and strong clinical adoption could drive significant revenue growth, gross margin expansion, and near-monopoly positioning in minimally invasive eye care. International expansion, potential litigation windfalls, and demographic trends create multiple underappreciated opportunities for diversified growth and enhanced long-term profitability.
View narrative
US$5.00
FV
17.6% undervalued
intrinsic discount
20.37%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
1 day ago
author updated this narrative
Value any company in seconds
Popular companies